Irreversible vision loss in antiphospholipid syndrome complicated by pre-eclampsia: a case presentation and

Sara Mirzaeian1, Saeed Zarrabi2, Mahdieh Mottaghi3

  • 1Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

PubMed

Insights

This case study details a pregnant patient with antiphospholipid syndrome (APS) who experienced irreversible vision loss due to severe pre-eclampsia, despite standard anticoagulant therapy. It emphasizes the need for vigilant monitoring and intervention in high-risk pregnancies.

Area of Science:

  • Obstetrics and Gynecology
  • Ophthalmology
  • Rheumatology

Background:

  • Pre-eclampsia can cause reversible visual disturbances.
  • Antiphospholipid syndrome (APS) is a known risk factor for obstetric complications.
  • Severe pre-eclampsia in APS patients can lead to catastrophic outcomes.

Purpose of the Study:

  • To present a case of irreversible visual loss in a patient with severe pre-eclampsia and APS.
  • To highlight the limitations of standard prophylactic treatment in preventing severe maternal morbidity.
  • To underscore the importance of close monitoring and timely intervention in high-risk pregnancies.

Main Methods:

  • Case report of an 18-year-old woman with APS, gravida 2, abortion 1.
  • Diagnosis of severe pre-eclampsia at 34 weeks gestation with highly triple positive antiphospholipid antibodies.
  • Management included aspirin, enoxaparin, cesarean section, and subsequent ophthalmologic interventions.

Main Results:

  • The patient developed bilateral visual loss secondary to serous retinal detachment and acute angle-closure glaucoma.
  • Despite treatment, vision did not recover, resulting in legal blindness at five-year follow-up.
  • This outcome occurred despite prophylactic aspirin and low molecular weight heparin (LMWH) therapy.

Conclusions:

  • Pregnant women with APS require meticulous monitoring for pre-eclampsia, even with standard anticoagulant prophylaxis.
  • Early and aggressive intervention is crucial to prevent severe visual impairment and other catastrophic outcomes.
  • This case emphasizes the need for tailored management strategies in high-risk pregnancies.
Abstract

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
481
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
5.5K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
394